See the DrugPatentWatch profile for eliquis

Eliquis: A Comprehensive Guide to the Popular Blood Thinner Medication

Eliquis is a prescription medication used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib). It is also used to treat deep vein thrombosis (DVT) and pulmonary embolism (PE). In this article, we will delve into the world of Eliquis, exploring its mechanism of action, benefits, side effects, and more.

What is Eliquis?

Eliquis is a direct oral anticoagulant (DOAC) that works by inhibiting the activity of factor Xa, a clotting factor in the blood. It is a combination of apixaban and other inactive ingredients. Eliquis is available in tablet form and is typically taken twice a day.

How Does Eliquis Work?

Eliquis works by blocking the activity of factor Xa, which is a key player in the blood clotting process. By inhibiting factor Xa, Eliquis prevents the formation of blood clots and reduces the risk of stroke and systemic embolism in patients with AFib.

Benefits of Eliquis

Eliquis has several benefits that make it a popular choice among patients and healthcare providers. Some of the benefits of Eliquis include:

* Effective in preventing stroke and systemic embolism: Eliquis has been shown to be effective in reducing the risk of stroke and systemic embolism in patients with AFib.
* Convenient dosing: Eliquis is taken twice a day, making it easy to incorporate into a patient's daily routine.
* Fewer bleeding complications: Eliquis has been shown to have a lower risk of bleeding complications compared to warfarin, a traditional anticoagulant.
* No dietary restrictions: Unlike warfarin, Eliquis does not require patients to follow a specific diet.

Side Effects of Eliquis

Like all medications, Eliquis can cause side effects. Some of the common side effects of Eliquis include:

* Nausea and vomiting: Eliquis can cause nausea and vomiting in some patients.
* Abdominal pain: Eliquis can cause abdominal pain in some patients.
* Fatigue: Eliquis can cause fatigue in some patients.
* Dizziness: Eliquis can cause dizziness in some patients.

Precautions and Contraindications

Eliquis is not suitable for everyone. Patients with certain medical conditions or taking certain medications may need to avoid taking Eliquis. Some of the precautions and contraindications for Eliquis include:

* Pregnancy and breastfeeding: Eliquis is not recommended for pregnant or breastfeeding women.
* Kidney or liver disease: Patients with kidney or liver disease may need to take a lower dose of Eliquis.
* Bleeding disorders: Patients with bleeding disorders may need to avoid taking Eliquis.

Patent Information

Eliquis is a patented medication, and its patent is set to expire in 2027. According to DrugPatentWatch.com, the patent for Eliquis was filed in 2007 and was granted in 2011. The patent is owned by Bristol-Myers Squibb and Pfizer.

Conclusion

Eliquis is a popular blood thinner medication used to prevent stroke and systemic embolism in patients with AFib. It is a convenient and effective medication that has few side effects and no dietary restrictions. However, it is not suitable for everyone, and patients with certain medical conditions or taking certain medications may need to avoid taking Eliquis.

FAQs

1. What is Eliquis used for?
Eliquis is used to prevent stroke and systemic embolism in patients with non-valvular atrial fibrillation (AFib).
2. How does Eliquis work?
Eliquis works by inhibiting the activity of factor Xa, a clotting factor in the blood.
3. What are the benefits of Eliquis?
Eliquis has several benefits, including being effective in preventing stroke and systemic embolism, convenient dosing, fewer bleeding complications, and no dietary restrictions.
4. What are the side effects of Eliquis?
Common side effects of Eliquis include nausea and vomiting, abdominal pain, fatigue, and dizziness.
5. Is Eliquis suitable for everyone?
Eliquis is not suitable for everyone, and patients with certain medical conditions or taking certain medications may need to avoid taking Eliquis.

Cited Sources

1. Bristol-Myers Squibb and Pfizer. (2011). Eliquis Prescribing Information.
2. DrugPatentWatch.com. (n.d.). Eliquis Patent Information.
3. American Heart Association. (n.d.). Atrial Fibrillation.
4. National Institute of Health. (n.d.). Deep Vein Thrombosis.
5. National Institute of Health. (n.d.). Pulmonary Embolism.